Samsung Pharmaceutical
KOSPI · Healthcare · ₩120B
₩1,260+0.48%
Price
1274.0원
1254.0원
Jul 24, 26Oct 27, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue₩9.9B+9.8%
Operating Income-₩5.0B-163.4%
Net Income-₩56.6BTurned to loss
3/'26 vs prev quarter
Company Health
Market Cap₩120B
Operating Margin-37.8%
Cash on Hand96억원7.9% of market cap
Free Cash Flow-58억원-4.8% of market cap
Short Volume 5.7% · as of 26.10.27
Among 97 제약 peers
LowMedianHigh
PSR2.8xmedian 0.7xPBR1.7xmedian 0.8xROE-189.8%median +5.2%
